Alphabet Inc.
13F Reported Value
ⓘ$99.1B
Holdings
28
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Alphabet Inc. disclosed 28 positions worth $99.1B in its Form 13F-HR for Q2 2026, led by $SPCX (SPACE EXPLORATION TECHNOLOGIES CORP) at 95.0% of the equity portfolio, followed by $PL and $ASTS. During the quarter the fund opened 3 new positions and exited 1 — including a new stake in $SPCX and a full exit from $TNYA. The portfolio is most concentrated in Technology (97.3% of disclosed assets). All figures are sourced directly from Alphabet Inc.’s Form 13F-HR filing with the SEC under CIK 1652044.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- $94.2B551,189,500 sh
- 38.4#2,193
Quality
$1.2B35,248,893 sh - 30.8#2,479
Quality
$794.7M8,943,486 sh - 69.5
Quality
$769.4M3,484,020 sh - —
Quality
$695.2M1,960,784 sh - —
Quality
$551.8M2,946,619 sh - 68.6
Quality
$164.0M16,206,643 sh - —
Quality
$134.6M4,919,498 sh - 41.2
Quality
$89.9M1,551,102 sh - 56.8
Quality
$83.2M2,724,712 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 SPACE EXPLORATION TECHNOLOGIES CORP$SPCX | — | $94.2B | 551,189,500 |
 Planet Labs PBC$PL | 38.4#2,193 | $1.2B | 35,248,893 |
 AST SpaceMobile, Inc.$ASTS | 30.8#2,479 | $794.7M | 8,943,486 |
 CME GROUP INC.$CME | 69.5 | $769.4M | 3,484,020 |
 ARM HOLDINGS PLC /UK$ARM | — | $695.2M | 1,960,784 |
 Revolution Medicines, Inc.$RVMD | — | $551.8M | 2,946,619 |
 Freshworks Inc.$FRSH | 68.6 | $164.0M | 16,206,643 |
 Parabilis Medicines, Inc.$PBLS | — | $134.6M | 4,919,498 |
 Tempus AI, Inc.$TEM | 41.2 | $89.9M | 1,551,102 |
 Gitlab Inc.$GTLB | 56.8 | $83.2M | 2,724,712 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Alphabet Inc.'s 28 positions.
Showing top 10 of 28 holdings.
Sector Allocation
Technology
$96.5B
Healthcare
$899.3M
Financials
$835.1M
Communication Services
$794.7M
Utilities
$51.5M
Industrials
$44.8M
Full Holdings — Alphabet Inc. (Q2 2026)
All 28 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $SPCX | SPACE EXPLORATION TECHNOLOGIES CORP | $94.2B | 95.0% | NEW | — |
| 2 | $PL | Planet Labs PBC | $1.2B | 1.2% | +0% | 38.4 |
| 3 | $ASTS | AST SpaceMobile, Inc. | $794.7M | 0.8% | +0% | 30.8 |
| 4 | $CME | CME GROUP INC. | $769.4M | 0.8% | +0% | 69.5 |
| 5 | $ARM | ARM HOLDINGS PLC /UK | $695.2M | 0.7% | +0% | — |
| 6 | $RVMD | Revolution Medicines, Inc. | $551.8M | 0.6% | -11% | — |
| 7 | $FRSH | Freshworks Inc. | $164.0M | 0.2% | +0% | 68.6 |
| 8 | $PBLS | Parabilis Medicines, Inc. | $134.6M | 0.1% | NEW | — |
| 9 | $TEM | Tempus AI, Inc. | $89.9M | 0.1% | +0% | 41.2 |
| 10 | $GTLB | Gitlab Inc. | $83.2M | 0.1% | +0% | 56.8 |
| 11 |  $PATH | UiPath, Inc. | $76.5M | 0.1% | +0% | 69.9 |
| 12 |  $LIFE | Ethos Technologies Inc. | $65.7M | 0.1% | -4% | 21.7 |
| 13 |  $PRME | Prime Medicine, Inc. | $61.1M | 0.1% | +0% | 30.7 |
| 14 |  $FRVO | Fervo Energy Co | $51.5M | 0.1% | NEW | — |
| 15 |  $PAYP | PayPay Corp | $44.8M | 0.1% | +0% | — |
| 16 |  $MAZE | Maze Therapeutics, Inc. | $41.4M | 0.0% | +0% | 10.3 |
| 17 |  $RLAY | Relay Therapeutics, Inc. | $26.4M | 0.0% | -10% | 19.5 |
| 18 |  $BBOT | BridgeBio Oncology Therapeutics, Inc. | $21.5M | 0.0% | +0% | — |
| 19 |  $OSCR | Oscar Health, Inc. | $13.7M | 0.0% | +0% | 83.1 |
| 20 |  $BEAM | Beam Therapeutics Inc. | $11.0M | 0.0% | +0% | 34.2 |
| 21 |  $VERA | Vera Therapeutics, Inc. | $10.4M | 0.0% | +0% | — |
| 22 |  $SANA | Sana Biotechnology, Inc. | $9.8M | 0.0% | +0% | — |
| 23 |  $GLUE | Monte Rosa Therapeutics, Inc. | $9.0M | 0.0% | -46% | 30.3 |
| 24 |  $LYEL | Lyell Immunopharma, Inc. | $4.1M | 0.0% | +0% | 9.3 |
| 25 |  $FIG | Figma, Inc. | $3.9M | 0.0% | +0% | 43.9 |
| 26 |  $SPRO | Spero Therapeutics, Inc. | $2.0M | 0.0% | +0% | 57.6 |
| 27 |  $HYPR | Hyperfine, Inc. | $1.2M | 0.0% | +0% | — |
| 28 |  $AUTL | Autolus Therapeutics plc | $1.1M | 0.0% | +0% | — |
New Positions (3)
Exited Positions (1)
$TNYA Tenaya Therapeutics, Inc.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Alphabet Inc. including:
Track Alphabet Inc.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Alphabet Inc. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Alphabet Inc.
13F Pro is an AI hedge fund tracker and stock research platform. For Alphabet Inc. (SEC CIK: 1652044), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Alphabet Inc.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.